These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35149167)

  • 1. Comparing the standard surgical dressing with dehydrated amnion and platelet-derived growth factor dressings in the healing rate of diabetic foot ulcer: A randomized clinical trial.
    Mohammadi Tofigh A; Tajik M
    Diabetes Res Clin Pract; 2022 Mar; 185():109775. PubMed ID: 35149167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogel dressings for healing diabetic foot ulcers.
    Dumville JC; O'Meara S; Deshpande S; Speak K
    Cochrane Database Syst Rev; 2011 Sep; (9):CD009101. PubMed ID: 21901730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alginate dressings for healing diabetic foot ulcers.
    Dumville JC; O'Meara S; Deshpande S; Speak K
    Cochrane Database Syst Rev; 2012 Feb; (2):CD009110. PubMed ID: 22336860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics.
    Tettelbach W; Cazzell S; Reyzelman AM; Sigal F; Caporusso JM; Agnew PS
    Int Wound J; 2019 Feb; 16(1):19-29. PubMed ID: 30136445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial.
    Edmonds M; Lázaro-Martínez JL; Alfayate-García JM; Martini J; Petit JM; Rayman G; Lobmann R; Uccioli L; Sauvadet A; Bohbot S; Kerihuel JC; Piaggesi A
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):186-196. PubMed ID: 29275068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.
    Embil JM; Papp K; Sibbald G; Tousignant J; Smiell JM; Wong B; Lau CY
    Wound Repair Regen; 2000; 8(3):162-8. PubMed ID: 10886806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of wound duration on diabetic foot ulcer healing: evaluation of a new sucrose octasulfate wound dressing.
    Lobmann R; Grünerbel A; Lawall H; Lüdemann C; Morbach S; Tigges W; Völkel L; Rychlik RP
    J Wound Care; 2020 Oct; 29(10):543-551. PubMed ID: 33052796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory role of Tinospora cordifolia as an adjuvant in surgical treatment of diabetic foot ulcers: a prospective randomized controlled study.
    Purandare H; Supe A
    Indian J Med Sci; 2007 Jun; 61(6):347-55. PubMed ID: 17558098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
    Wieman TJ; Smiell JM; Su Y
    Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of adequate debridement and placental-derived allografts on diabetic foot ulcers.
    Tettelbach WH; Cazzell SM; Hubbs B; Jong JL; Forsyth RA; Reyzelman AM
    J Wound Care; 2022 Sep; 31(Sup9):S16-S26. PubMed ID: 36113857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
    DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Jacobs AM; Zelen CM
    Int Wound J; 2018 Dec; 15(6):950-957. PubMed ID: 30019528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers.
    Niezgoda JA; Van Gils CC; Frykberg RG; Hodde JP
    Adv Skin Wound Care; 2005 Jun; 18(5 Pt 1):258-66. PubMed ID: 15942317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial.
    Cazzell SM; Caporusso J; Vayser D; Davis RD; Alvarez OM; Sabolinski ML
    J Wound Care; 2024 Jul; 33(Sup7):S4-S14. PubMed ID: 38973638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success.
    Saco M; Howe N; Nathoo R; Cherpelis B
    Dermatol Online J; 2016 Aug; 22(8):. PubMed ID: 27617934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized, Controlled Clinical Trial of Honey-Impregnated Dressing for Treating Diabetic Foot Ulcer.
    Imran M; Hussain MB; Baig M
    J Coll Physicians Surg Pak; 2015 Oct; 25(10):721-5. PubMed ID: 26454386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential cost-effectiveness of using adjunctive dehydrated human amnion/chorion membrane allograft in the management of non-healing diabetic foot ulcers in the United Kingdom.
    Guest JF; Atkin L; Aitkins C
    Int Wound J; 2021 Dec; 18(6):889-901. PubMed ID: 33827144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers.
    Shukrimi A; Sulaiman AR; Halim AY; Azril A
    Med J Malaysia; 2008 Mar; 63(1):44-6. PubMed ID: 18935732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes.
    Jeffcoate WJ; Price PE; Phillips CJ; Game FL; Mudge E; Davies S; Amery CM; Edmonds ME; Gibby OM; Johnson AB; Jones GR; Masson E; Patmore JE; Price D; Rayman G; Harding KG
    Health Technol Assess; 2009 Nov; 13(54):1-86, iii-iv. PubMed ID: 19922726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study on topical bismuth subgallate/borneol (Suile) dressing for treatment of diabetic foot ulcers].
    Wang F; Yuan N; Wang Y; Wang C; Wang A; Yu T; Liu G; Xu Z; Ran X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Aug; 26(8):955-60. PubMed ID: 23012931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.